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This brief survey covers the main events in the evolution of eukaryotic genes in broad brush style. It
concentrates on regulatory DNA, an area that has been relatively neglected, and where we believe that the
present case-by-case analysis is likely to be supplemented by more general, genomics-based methods. It is
biased towards immunology, in part because the immune system relies heavily on polymorphism of regulatory
DNA to provide flexibility and in part because of our own field of interest. It gives a central place to recent
work that has shown how analysis of electronic genomes can be used to trace gene duplication and its
consequences. It mentions cellular systems that offer models for the study of evolution of regulatory DNA
on a small scale. It alludes to the unanswered question of how genomes adjust their overall size.
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The subject of this review can be put in the
following nutshell. A century and a half has passed
since we learned to interpret form in terms of
function and evolution. Several decades have
passed since we learned to do the same for coding
genes and protein structure. Yet for regulatory
DNA we have hardly begun. This is reflected in the
fact that EMBOSS (the European Molecular Biology
Open Software Suite) contains 43 programs for
handling proteins, and just one for regulatory
DNA. The gap is remarkable, as it is now widely
accepted that a full understanding of form and
function in biology depends ultimately on
knowing when, where and how much individual
genes are expressed (Carroll  2000, Davidson
2001).
The current edition of The Molecular Biology
of the Cell demonstrates where we now stand
(Alberts  et al.2002). It illustrates transcription
factors assembling around RNA polymerase2 at the
start of transcription site, but the figures are purely
diagrammatic and make no attempt to show the
way the DNA folds or to present a three
dimensional structure. At present we know only
that the full structures will be enormously difficult
to solve – at least an order of magnitude more
difficult than solving the structure of any single
protein. And an understanding will be even harder
to obtain of how such a structure operates and
could have evolved.
This is an area hitherto dominated by
biochemistry, using such tools as EMSA
(electrophoretic mobility shift assay), foot printing,
reporter constructs and so on. Nevertheless we are
convinced that the genomics based evolutionary
approach has much to offer. Close examination of
how promoters have evolved, particularly in micro-
evolution, will surely contribute to the final
solution. This review therefore deals with the
following three questions:
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1. How far has the genomic approach got in
identifying regulatory DNA?
2. What can we learn from the pattern of variation
in the DNA thus identified?
3. Can we in this way build a picture of the
evolution of regulatory DNA?
To clarify, most regulatory DNA is contained
within the promoter region upstream of coding
sequences, but it would be a mistake simply to
equate regulatory function with that location.
Important regulatory activity has been detected far
upstream of the proximal promoter region, within
introns, and downstream of the coding regions.
Rather, the question is whether functionally active
sequences can be identified directly from their
sequence properties, rather than operationally.
Recent mainstream approaches to this problem have
been reviewed elsewhere (Stormo  2000, Fujibuchi
et al. 2001, Coleman et al. 2002). Questions one and
two are closely linked, for functional activity can up
to a point be identified from the pattern of variation
(conservation of transcription factor binding sites,
but with functionally active variation grouped
around them). Question three is also closely linked,
as an important test of functional activity is whether
it is conserved during evolution.
Recent surveys emphasize the importance of
regulatory gene sequences in evolution, but
without taking us far into detail (Mitchison 1997,
Carroll  2000, Enard et al. 2002). Often cited is the
striking study of domestication in maize from its
teosinte ancestor. A major area of research is the
multifactorial diseases of man and their animal
models. This has yielded conspicuous associations
of disease susceptibility with polymorphisms in
regulatory DNA (Mitchison 2001), notably in
autoimmune (Becker et al. 1998) and cardiovascular
disease (Pailard et al. 1999). We exclude from this
generalization the special case of polymorphism
in the coding sequences of the “extrovert” genes,
which encode proteins such as hemoglobin and
the MHC (major histocompatibility complex) that
bind directly to parasite and other foreign
molecules (Mitchison 1997). These are where the
“red queen” evolutionary strategy enlarges
structural diversity (Sasaki et al. 2002). We also
exclude from consideration microbial evolution,
which has its own rules. So far these instances of
domestication and disease association have been
studied largely on a case-by-case basis; the
question now is whether they can be brought
together by the application of genomics.
W e note that India plans to invest heavily in
genomics research (Mudur 2001), and hope that the
approaches discussed here will proved relevant.
Birth and Subsequent Modification of Genes
Gene duplication has generally been regarded as a
necessary source of evolutionary novelty. A recent
study of the origin and subsequent fate of
duplicated genes is based on the genomes of man,
mouse, chicken, nematode, fly, rice, Arabidopsis,
and yeast (Lynch &  Conery 2000, see also further
discussion in the same journal). Each known open
reading frame (after appropriate filtration) was
compared with all others from the same species so as
to identify gene duplicates, and diversity between
the duplicates was then analyzed for nucleotide
substitution at replacement (R) versus silent (S)
codon sites. The R/S ratio is a useful parameter,
since silent substitutions provide a “biological
clock”, while replacements measure the pressure of
natural selection. The study yielded important
information about the survival, modification and
silencing (death) of duplicated genes. For our present
purpose it demonstrates two important points. One
is that plants are relatively rich in duplications, a point
that has a long history tracing back to their high level
of chromosomal rearrangements that provide
plasticity in adapting to varied environments
(Barnes 2002, Comai 2000). Plants occupy a high
position on the genomics agenda. The second point
is that duplicated genes that have diverged in their
coding sequences can routinely be identified in the
published electronic data bases by genomics. The
promoters of these genes could potentially be
tracked, and should provide extensive material for
further genomic analysis.
Limited gene sets are already being subjected
to this type of analysis. For instance the alpha
interferon genes have undergone extensive
duplication, with as many as fifteen serially
duplicated genes running along human
chromosome 9. Their coding sequences show only
minor variation, and it seems likely that it is the
need to make different responses in different cell
types that maintains this extensive duplication. One
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promoter variant in these genes has already been
shown to alter the response of reporter constructs
(Raj  et al. 1991). It is likely that the same kind of
analysis could also be applied to chemokines
(Yoshie et al. 2001).
These are approaches based on intraspecies
analysis. Clearly comparison between species can
yield further information of the same sort. For both
types of analysis the interval since the start of
diversification is critical. If the interval is too short the
extent of diversification may be too small, and if too
long the informative diversification may get
swamped by accumulation of random polymorphism
(junk DNA). With long intervals, for instance in trans-
family comparisons within the MHC, the only
feature of a promoter that is conserved may be the
canonical transcription factor binding sites (Benoist
&  Mathis 1990). The variation around these sites
may be what is most informative, but may no longer
be detectable because of the surrounding junk. In
this kind of analysis what matters is the variation
that is maintained by selection. For man the most
informative comparison may be with the apes,
although it is too early to be sure (Enard et al. 2002).
Indeed drawing the limits of informative comparison
will be an important task for the future genomics,
with different types of gene no doubt having
different limits.
Poaching
In this and the following section we mention
approaches that have not yet yielded subject matter
for genomics, but which we suspect will eventually
do so. Viruses occasionally pick up host genes and
incorporate them into their own genomes. Because
viruses evolve so fast this poaching provide
valuable information about the evolution of
regulation. Herpes viruses are conspicuous
examples; where 10 – 15% of the ~100 genes in their
genome have been acquired in this way (Alba et al.
2001a,b). They comprise a large family of viruses,
within which some 4,000 genes have so far been
sequenced and subjected to genomic analysis. They
offer rich material for study of the evolution of
regulatory DNA sequences. It seems that these
viruses must often evolve their own regulatory
DNA, since the viral genes of host origin usually lack
introns and must therefore have been picked up
from host mRNA. Nevertheless their regulatory
DNA cannot be entirely independent of the host,
since it depends on the host cell for much of its
machinery of expression.
Crippling
Sometimes genes come under strong selective
pressure. Cancer is an outstanding example,  where
proteins not required for cell survival or growth tend
to be dispensed with, and those that mediate drug
resistance get over expressed. Two groups of studies
have examined these effects on regulatory DNA
sequences. One is in the Reed-Sternberg cell, believed
to be the central culprit in Hodgkin’s Lymphoma. This
cell is related to the B cell, as it has rearranged
immunoglobulin genes although these are trans-
criptionally inactive. Reed-Sternberg cells have been
found with an immunoglobulin promoter that is
“crippled” by mutation in the immunoglobulin
octamer, although this form of inactivation seems to
be unusual (Theil et al. 2001). Crippling mutations
have also been found in the Fas promoter, again
consonant with the needs of a cancer cell (Muschen
et al. 2000). Crippled MHC gene promoters have
been found in melanoma cell lines, consonant with
the dispensed-function hypothesis but consonant
also with the hypothesis of immune surveillance
(Lee et al. 2000). In the UK, we understand from
personal information that of the Cancer Genome
Project of the Wellcome Trust Genome Campus at
Hinxton has for the time being chosen not to
investigate mutation in regulatory DNA, although
that may change.
Another approach would be to put promoters
under pressure in an experimental system. Here
again there is some background information from
experiments with the MHC. Many years ago
George Snell, the co-discoverer of the MHC, bred
congenic mouse strains in which the MHC from one
strain was introduced into another by back-
crossing, which at the time represented an important
step forward in understanding the MHC. It thus
became possible to breed mice hemizygous for a
congenic MHC, induce cancer, and then immuno-
select the cancer cells (by transplantation) for loss of
one of the two “allelic” MHC’s. Two groups
thought–at least for a while – that they had
succeeded in doing so (Mitchison 1956, Dalianis
et al. 1981). However, the work was never pursued
to the point where immunoselection was applied to
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the product of a single gene (the full classical MHC of
the mouse is now known to have five linked loci).
W ith modern knowledge of the MHC this is
something that could easily be done, and would
seem to offer a fair chance of picking up crippling
mutations in the MHC promoters. Furthermore it
would be of interest to perform the immune
selection in vitro as well as in vivo. Monoclonal
antibodies could be used to select against any of a
wide range of single gene products expressed on the
cell surface. Indeed selection for or against
expression of any gene of interest, by one means or
another, could be of interest.
Promoter Variation Reflects Variation in
Coding Sequences
It has long been realized that variation in one set of
coding sequences can select for variation in other
linked sequences, a process referred to as hitch-
hiking (Smith &  Haigh 1974). The MHC is a good
place to look for such an effect, because of the high
level of polymorphism in coding sequences
maintained by balancing selection (heterozygote
advantage). Such an effect has indeed been found,
over distances far longer than the classical promoter
(Beck  & Trowsdale  2000). Yet it seems likely that
MHC promoters would also be subject to direct
natural selection. To try to sort out these two
effects, we sequenced a series of murine MHC
promoters mainly derived from wild mice
(Mitchison & Roes 2002). The upshot was that both
effects seem to operate. Linkage disequilibrium
with polymorphic coding sequences – hitch hiking
– seems necessary to maintain extensive promoter
polymorphism. The most telling support for this
view comes from study of CIITA (Class II trans-
activator). This gene is a major modulator of MHC
II expression, yet being non-polymorphic in its
coding sequences it is also non-polymorphic in its
promoter. On the other hand the hitch hiking effect
is clearly not sufficient to account for all the features
of MHC promoter polymorphism. Although these
MHC II promoters are extraordinarily diverse, a set
of MHC class I promoters from the same genomic
D N A that we also sequenced showed little diversity.
As MHC I coding sequences are as diverse as those
of MHC II, we attributed the difference to the
greater range of selective pressures operating on
MHC II gene expression. Furthermore, the
polymorphic residues in the MHC II promoters
were predominantly located near transcription
factor binding sites.
W e also examined human MHCII promoters
(Held et al. submitted). We employed a biophysical
approach to detect the ability of varying promoter
sequences to bind transcription factors. First we
obtained synthetic samples of naturally occurring
oligonucleotides that varied slightly in  sequence.
Each oligonucleotide was then tested for its ability
to bind nuclear extracts, by means of plasmon
resonance. The only variation that affected the
level of binding occurred in sequences adjacent to
the TATA box. Furthermore this effect could be
verified by showing that the oligonucleotides
detected in this way also yielded different values
by EMSA (the electrophoresis mobility shift assay
mentioned above).
The general message is that in any systematic
scan for promoter variation it would make sense to
pay special attention to genes with polymorphic
coding sequences. They seem to be where a
meaningful distribution of variable residues is most
likely to occur. The known mouse MHC II promoter
variants provide a model of what can be hoped for
and their further exploration has become an urgent
matter. We need to know whether reporter
constructs can be used to explore their functional
consequences. It would be particularly helpful to learn
whether, for instance, substitutions near the CRE
sequence (the cyclic-AMP response element) alter the
response to agents that regulate the cAMP level.
Ultimately, we need to explore gene-reshuffling,
where different promoters would be tested in vivo
for their effect on the same coding sequence.
Gene D imorphism
An unexpected feature of the polymorphism
emerged during the above study of mouse MHC
II promoters. To our surprise, each of the three
promoters under study turned out to have two
basic polymorphic type, each made up of a linked
series of alternative nucleotide substitutions.
The separation into two haplotypes was not
complete, as limited recombination between
different sites within each promoter evidently
takes place. The haplotypes were not in linkage
disequilibrium between the three loci. Thus we
were confronted with three instances of
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promoter dimorphism, for which we had no
explanation. Enlarging on this limited data, we
speculated that dimorphism (in either regulatory
or coding sequences) may play a part in the birth
and death of genes. Conceivably, we proposed,
it may assist newly duplicated genes to diversify
at the early time when one of the pair is at
greatest risk of extinction. A dimorphic gene
might duplicate and subsequently recombine
with the old, non-duplicated gene of the opposite
dimorphic type, thus generating a new
chromosome in which the two dimorphic types
are both present in tandem.
A second possibility, we proposed, is that
dimorphism could assist the loss of function of
a duplicated gene. One member of a pair of
duplicated genes (that have undergone
differentiation) might develop a dimorphism, in
which one of the haplotypes mimics the function
of the other duplicated gene. This would make
the other gene redundant, and leaves it prone to
extinction. We proposed that this could explain
why the H2E gene so often looses function, since
its function is mimicked (up to a point) by one of
the dimorphic haplotypes at H2A.
These two possibilities are opposed to one
another, in a way that might be expected of genomes
that seem to vary habitually in size. This is all highly
speculative, and hardly worth mentioning except
that promoter dimorphism does not seem to have
been encountered previously. It would be worth
keeping an eye out for in the future.
Culling
Granted that genes undergo unending cycles of
birth and death by loss of function, how come that
the genome does not fill up with pseudogenes?
Interpreting their work on the compact genome,
Venkatesh et al. (2000) ask “Is the Fugu gene
density a primitive trait retained from the ancestral
duplicate invertebrate genome? This seems
unparsimonious, as the pufferfish belongs to a
highly derived teleost lineage, and the majority of
teleosts that diverged earlier from the ancestral
lineage have larger genomes. It seems more likely
that a strong bias towards deletions in the Fugu has
compacted the genome.”. About the nature of that
bias the Brenner group has nothing to say, and nor
do we. Machinery for culling does seem to exist,
and in general presumably serves to keep the
genome within bounds of some sort. We are left
with an  important but unanswered question.
From Informatics to Experiment, and Back Again
The scope outlined here for future genomics calls for
the gathering of further data, particularly in the
areas of (i) population genetics, (ii) biochemistry
with reporter constructs, EMSA and plasmon
resonance and (iii) reversed genetics with promoter
reshuffling. In population genetics we expect
increasing use will be made of DNA banks, such as
that mentioned here of mice offered by the Jackson
Laboratory. These data will in turn demand further
genomics. The trade will be two-way, and will
require scientists able to handle both approaches.
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